LIU Tong

Partner, WM Partner

Areas of expertise: Ophthalmology Drug and Medical Devices

Tong is a former partner of Shenzhen GTJA Investment Group Co., Ltd. and managing director of Songhe Capital, with more than three years of direct investment experience in oncology precision medicine and ophthalmic drugs. She founded UBreath and served as CEO there. She has more than 10 years of senior management experience in pharmaceutical multinational companies and has worked at Beijing Hanmei, Sanofi, GSK, Hisun Pfizer, etc. She received her doctorate in gene medicine and gene vaccine from the Genetic Center of Southeast University in Nanjing, China.